Movement Alert｜Kelun-Biotech Rises 3.16% in Regular Trading, Biotech Sector Broadly Rallies Amid Positive Analyst Coverage

Market Focus

Jun 23

On June 23, Kelun-Biotech (06990.HK) rose 3.16% in regular trading, trading at 405.8 HKD/share, with turnover of approximately 33.53 million HKD. The stock rebounded after a 3.7% decline in the previous session.

The Biotechnology sector where Kelun-Biotech belongs saw broad strength. Among individual stocks, AKESO up 4.34%, BEIGENE up 3.6%, REMEGEN up 3.82%, INNOVENT BIO up 3.12%, while TRANSTHERA-B fell 56.66%.

On the news front, Xingye Securities recently initiated coverage on Kelun-Biotech with an Overweight rating following the company's oral presentation at ASCO of Phase III OptiTROP-Lung05 data for sac-TMT combined with Keytruda in first-line PD-L1 TPS≥1% NSCLC. The broker forecasted revenue of 3.587 billion, 4.355 billion, and 6.712 billion yuan for the next three years respectively, citing global best-in-class potential for its core ADC pipeline.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1136377069"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1136377069\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1136377069?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-23 09:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1136377069","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Kelun-Biotech Rises 3.16% in Regular Trading, Biotech Sector Broadly Rallies Amid Positive Analyst Coverage","media":"Market Focus","content":"<p><p>On June 23, Kelun-Biotech (06990.HK) rose 3.16% in regular trading, trading at 405.8 HKD/share, with turnover of approximately 33.53 million HKD. The stock rebounded after a 3.7% decline in the previous session.</p><p>The Biotechnology sector where Kelun-Biotech belongs saw broad strength. Among individual stocks, AKESO up 4.34%, BEIGENE up 3.6%, REMEGEN up 3.82%, INNOVENT BIO up 3.12%, while TRANSTHERA-B fell 56.66%.</p><p>On the news front, Xingye Securities recently initiated coverage on Kelun-Biotech with an Overweight rating following the company's oral presentation at ASCO of Phase III OptiTROP-Lung05 data for sac-TMT combined with Keytruda in first-line PD-L1 TPS≥1% NSCLC. The broker forecasted revenue of 3.587 billion, 4.355 billion, and 6.712 billion yuan for the next three years respectively, citing global best-in-class potential for its core ADC pipeline.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Kelun-Biotech Rises 3.16% in Regular Trading, Biotech Sector Broadly Rallies Amid Positive Analyst Coverage</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Kelun-Biotech Rises 3.16% in Regular Trading, Biotech Sector Broadly Rallies Amid Positive Analyst Coverage\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-23 09:57</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 23, Kelun-Biotech (06990.HK) rose 3.16% in regular trading, trading at 405.8 HKD/share, with turnover of approximately 33.53 million HKD. The stock rebounded after a 3.7% decline in the previous session.</p><p>The Biotechnology sector where Kelun-Biotech belongs saw broad strength. Among individual stocks, AKESO up 4.34%, BEIGENE up 3.6%, REMEGEN up 3.82%, INNOVENT BIO up 3.12%, while TRANSTHERA-B fell 56.66%.</p><p>On the news front, Xingye Securities recently initiated coverage on Kelun-Biotech with an Overweight rating following the company's oral presentation at ASCO of Phase III OptiTROP-Lung05 data for sac-TMT combined with Keytruda in first-line PD-L1 TPS≥1% NSCLC. The broker forecasted revenue of 3.587 billion, 4.355 billion, and 6.712 billion yuan for the next three years respectively, citing global best-in-class potential for its core ADC pipeline.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06990","symbol_name":"科伦博泰生物","start_time":0,"source_url":"","article_id":"1136377069","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1136377069","pubTimestamp":1782179861,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 23, Kelun-Biotech (06990.HK) rose 3.16% in regular trading, trading at 405.8 HKD/share, with turnover of approximately 33.53 million HKD. The stock rebounded after a 3.7% decline in the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06990":"科伦博泰生物"},"translate_title":"走势提示|科伦生物常规交易涨3.16%分析师正面报道生物科技板块普遍上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06990":1},"content_text":"On June 23, Kelun-Biotech (06990.HK) rose 3.16% in regular trading, trading at 405.8 HKD/share, with turnover of approximately 33.53 million HKD. The stock rebounded after a 3.7% decline in the previous session.The Biotechnology sector where Kelun-Biotech belongs saw broad strength. Among individual stocks, AKESO up 4.34%, BEIGENE up 3.6%, REMEGEN up 3.82%, INNOVENT BIO up 3.12%, while TRANSTHERA-B fell 56.66%.On the news front, Xingye Securities recently initiated coverage on Kelun-Biotech with an Overweight rating following the company's oral presentation at ASCO of Phase III OptiTROP-Lung05 data for sac-TMT combined with Keytruda in first-line PD-L1 TPS≥1% NSCLC. The broker forecasted revenue of 3.587 billion, 4.355 billion, and 6.712 billion yuan for the next three years respectively, citing global best-in-class potential for its core ADC pipeline.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}